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Contrast-enhanced ultrasound (CEUS) is a real-time, feasible technique. Both 
intraoperatively and bedside, it satisfies the need for serial assessment and easy 
performability. Initially employed in neuro-oncology, it has recently overcome 
this first application. The chapter aims to give a comprehensive view of its use in 
oncological, vascular, and spinal neurosurgery. CEUS versatility across the afore-
mentioned areas is analyzed, underlining its complementarity to other well-settled 
imaging techniques. Its major oncological (both cerebral and spinal) and vascular 
(including aneurysms, AVMs, dAVFs, carotid plaques, and stroke) application and 
state of the art are discussed. The chapter is focused on reporting CEUS advantages 
and disadvantages, giving an insight to future perspectives and applications.
Keywords: contrast-enhanced ultrasound, CEUS, ultrasonography, brain tumors, 
spinal tumors, intraoperative imaging, neuro-oncology
1. Introduction
Neurosurgery is experiencing the rediscovery of intraoperative ultrasound 
(ioUS). In particular, growing enthusiasm was shown after the introduction of 
contrast-enhanced ultrasound (CEUS) in the field of neuro-oncology, following the 
leads of other surgeries such as thyroid and hepatic surgery. Besides this pioneering 
use in brain and spinal oncology, other applications including stroke, brain trauma-
tology, vascular neurosurgery, and peripheral nerve surgery [1–9] were reported.
Those experiences in literature proved the integration of ioUS and CEUS to be 
a valuable tool in different neurosurgical scenarios: it provides a truly real-time, 
feasible, and modern intraoperative imaging technique, allowing the assessment of 
unexposed, hidden, anatomical, and pathological structures [10] in both traditional 
and emerging settings.
2. CEUS in neurosurgery: where do we stand?
Standard B-mode ultrasound has been presented since several years in many 
neurosurgical operating rooms: it represented de facto one of the first tools to study 
anatomy through unexposed, hidden, parenchymal tissues. For this reason, it is 
incorrect to classify ioUS/CEUS use as an innovation, being it more a rediscovery: 
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ioUS has been employed in neurosurgery since the 1960s [11], and it granted 
intraoperative imaging and navigation well before more evolved technologies, such 
as intraoperative CT (iCT), intraoperative MRI (iMRI), indocyanine green video 
angiography (ICG-VA), and navigation, were broadly available [12–15]
Nonetheless, significant limitations of ioUS as a reliable and feasible application 
in neurosurgery were represented by both imaging interpretation, unfamiliar to 
neurosurgeons, and artifacts related to manipulation. A good evidence of this is 
that as surgical resection advances, the ioUS image quality decreases: due to surgi-
cally induced artifacts and edema, imaging interpretation becomes challenging [1]. 
Moreover, all information provided by ultrasound (US) relies on echogenicity of 
insonated structures: no dynamic information, such as overall vascularization, is 
given through standard B-mode ultrasonography.
Even though the aforementioned limitations could have prevented further 
research, major technological advancements in the US field, such as image fusion 
for navigation, CEUS, and elastosonography, have been developed; new applica-
tions in their usage in neurosurgery, although on a small scale, have constantly been 
achieved and reported in recent years [16–20].
Being capable of highlighting tumor tissue not relying on its echogenicity but 
on its vascularization, CEUS has been specifically found to be a versatile innova-
tion. Introduced in other medical branches, such as hepatic oncological surgery, the 
technique is feasible in both diagnostic and intraoperative settings: it allows prac-
titioners to differentiate between benign and malignant lesions, helps in localizing 
the target, and controls treatment efficacies [10, 19].
On the heel of these observations, CEUS intraoperative experiences have 
been borrowed to neurosurgery to overcome the strains of standard B-mode US 
imaging.
CEUS is a harmonic imaging modality that depicts the distribution of microbub-
ble contrast agent in tissues. Thanks to their structure, sulfur hexafluoride-filled 
lipidic microbubbles cannot diffuse to the interstitial space, giving a representa-
tion of the vascular district only. The degree of contrast enhancement (CE) is a 
consequence of the density of the capillaries, which in turn is proportional to tissue 
activity [19, 21].
Microbubbles are visible through a contrast-specific algorithm that permits a 
real-time assessment of contrast enhancement, measurement of vascularity of focal 
lesions during different dynamic phases, and analysis of tissue perfusion; CEUS 
algorithm suppresses the linear US echo, thus producing a specific representation 
only of the microbubbles. In other words, images are a direct representation of 
vascularization and become independent from tissue echogenicity. Furthermore, 
microbubbles, being micron-sized, are not able to extravasate from vessels and 
behave as a purely intravascular contrast agent, allowing to study all vascular tree 
districts: arterial, venous, and capillary [19, 22]. On these bases, CEUS has been 
introduced in neurosurgery for the intraoperative visualization of brain tumors: it 
is a dynamic modality which permits to visualize them according to their degree of 
vascularization [1, 23].
This first application has led to the following use in a variety of neurosurgical 
fields. As shown in the herein presented review, a consistent literature has been 
published describing CEUS use in settings other than cerebral neuro-oncology, 
including spinal oncology, vascular neurosurgery (cerebral and spinal), TBI, and 
pediatric and peripheral nerve surgery.
Besides their undisputed value, traditional intraoperative imaging techniques 
(CT scan and MRI) have several limitations, including costs, temporary stop of 
surgical procedure, and time wasting. These important strains make iCT and iMRI 
hardly repeatable during surgery [12, 24].
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Conversely, as demonstrated by several experiences, CEUS/ioUS is a feasible 
intraoperative imaging technique, as it is readily repeatable, dynamic, and inex-
pensive and provides a truly real-time dynamic visualization of anatomical char-
acteristics and vascular patterns in several neurosurgical settings. Assessment is 
rapid, can be performed any time during surgery, and is independent of brain shift 
[4, 8–10, 20].
Besides, microbubbles do not only allow the visualization of high-definition 
intraoperative images after craniotomy but, as reported later, can enhance the 
resolution of intracranial arteries also in transcranial studies at bedside [25–27].
Figure 1 summarizes the major fields of application of CEUS in neurosurgery.
3. Cerebral neuro-oncology
The use of CEUS during neuro-oncological procedures has been recently 
included in the guidelines from the European Federation of Societies for Ultrasound 
in Medicine and Biology (EFSUMB), representing a paradigm shift for the use of US 
in neurosurgery [28](Figure 2).
In comparison with other imaging modes, CEUS showed itself as a rapid, practi-
cal, and cost-effective technique, suggesting additional and alternative information 
about brain tumor vasculature and perfusion, being B-mode limited in providing 
only morphological information regarding the lesion. In their seminal study, Prada 
et al. [29] demonstrated how, once enhanced, the tumor is highlighted and reveals 
other specific characteristics of both low-grade gliomas (LGGs) and high-grade 
gliomas (HGGs).
LGGs show a mild, dotted CE with diffuse appearance and blurred margins. 
Arterial feeders are usually not identifiable, microbubble transit is regular and 
organized, and venous drainage is diffuse through numerous capillaries and conse-
quently not discernible. Relying not on its echogenicity but upon vascularization, 
CEUS proved to be particularly valuable in differentiating oncological tissue from 
surrounding edema, thus helping in depicting the true limits of infiltration [30, 31].
HGGs have a high CE with a more nodular, nonhomogeneous appearance and 
fast perfusion patterns, with a rapid CE, marked by rapid arterial phase, very fast 
CE peak, and chaotic transit of microbubbles within the lesion. The arterial supply 
Figure 1. 
Diagrammatic representation of the fields of application of CEUS in neurosurgery.
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was clearly visible, showing many macrovessels within the lesion and a typical 
peripheral enhancement that moved toward the inner areas of the lesion. The 
venous phase was rapid (5–10 seconds), and the venous drainage system was dif-
fuse, with multiple medullary veins aiming toward the periventricular zone. CEUS 
in HGGs is useful in differentiating solid from cystic components. In the specific 
case of glioblastomas (GBMs), CEUS CE is consistent in proliferating areas, and, 
on the contrary, no CE at all is seen in necrotic zones and surrounding brain paren-
chyma. Two CE patterns are identifiable in GBM: (1) heterogeneous with nodular 
high CE spots interspersed by low CE areas of necrosis and (2) peripheral rim CE 
surrounding a central core of necrosis without CE. In all cases, GBM shows a clearly 
demarcated border after UCA administration due to the different vascularization of 
the tumor and healthy brain parenchyma [29](Figure 3).
Highlighting the residual tumor tissue with great accuracy and overcoming the 
difficulties of ultrasound interpretation caused by artifacts, edema, and surgical 
manipulation [10, 23, 32], CEUS has been demonstrated valuable in guiding tumor 
resection. In conclusion, the introduction of CEUS embodies one of the most recent 
innovations in HGG surgery.
Furthermore, in a series of publications, CEUS showed its capability in identify-
ing tumor remnants after HGG surgery [10, 23, 30]. These are generally defined as 
nodular tissue at the edges of the surgical cavity, depicting an early and persistent 
enhancement, compared to the surrounding brain parenchyma. Because of artifacts 
due to surgical manipulation, B-mode evaluation alone can show unclear results if 
performed after neurosurgical resection. In the advanced phase of surgery, CEUS 
can fill the gap left by ioUS, guiding the surgeon also in the final survey at the end 
of the procedure [33]. Moreover, US is independent of brain shift, and this grants 
useful information to surgeons throughout the procedure also in advanced phases of 
resection, such as final survey at the end of the procedure.
CEUS potential in detecting inadvertent residuals proved particularly effective 
in a 5-ALA-guided setting [10], where the resection is built with the 5-ALA assis-
tance, and CEUS supplementary supports the surgeon by providing information 
before and after resection. Incomplete resections also in a 5-ALA setting can indeed 
result from residual tumor covered by blood, cottonoid, or overlapping normal 
brain: in these scenarios it does not light up under blue light conditions and can be 
missed [34–37]. Moreover, in deep fields or conditions of non-orthogonal working 
corridors, microscope light might fail to thoroughly illuminate the surgical field, 
resulting in blind corners facilitating a partial removal. Thus, CEUS final survey 
Figure 2. 
B-mode CEUS evaluation of a high-grade glioma. The microbubble contrast medium allows to visualize the 
tumor parenchyma with its necrotic non-enhancing component. In advanced phases of resection, CEUS can be 
repeated to identify inadvertent residuals.
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has a role of refinement of the 5-ALA procedure by identifying sub-centimetric 
remnants. The two techniques approach the surgical field from a different point 
of view: 5-ALA fluorescence is a result of direct microscope illumination, whereas 
ultrasounds investigate through brain tissue, depicting also distant, unexposed, 
hidden cerebral or neoplastic anatomy. Indeed, they observe two different phenom-
ena: 5-ALA is an expression of glial cell metabolism, whereas CEUS is a consequence 
of pathological tumor vascularization. When integrated, these complementary 
techniques increase the chance of identifying neoplastic residual tissue.
CEUS-assisted intraoperative imaging does not modify the overall surgical pro-
cedure, as it does not interrupt the central phase of surgery and the overall surgical 
strategy, is not time demanding, and does not require expensive equipment; these 
considerations are surely important, especially when compared with other intraop-
erative imaging techniques.
Also, CEUS provides other valuable information to identify vascular supply, 
giving further insight into the surgical strategy, facilitating vascular deafferentation 
and removal, and thus maximizing resection voiding neurological sequelae result-
ing from damaged healthy brain tissues or vessels [38].
Serious weaknesses of CEUS in vascularization assessment are angle of 
insonation susceptibility, low-flow veins not always visible, and small vessel 
overestimation due to blooming artifacts that scatter color signals nearby the 
vessel margins [17]. Possible limitations in the assessment of resection margin are 
Figure 3. 
CEUS visualization of lesion’s vascular characteristics of a hemangiopericytoma of the cauda equina after 
CEUS—The exams depict the main feeders afferent to the lesion (red arrowheads) and the main venous 
drainage outgoing the lesion (blue arrows). The tumor is highly and rapidly enhancing after intraoperative 
contrast administration confirming its highly vascularized characteristics. Vessels not directly related to the 
tumor and belonging to conus medullaris can be identified (green asterisk).
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evaluating the tumor removal degree of patients with recurrent gliomas or patients 
with gliomas after radiotherapy [39].
CEUS can also be compared with perfusion MRI in both preoperative and post-
operative settings: US offers a morphologic representation of GBM similar to the 
one provided by preoperative gadolinium-enhanced T1-weighted MRI [40]. Several 
experiences in literature compared, instead, CEUS with pMRI in a postoperative 
setting [41, 42] and suggested it as a cost-effective method in evaluating changes in 
tumor vascularity during the follow-up period in patients with brain tumors who 
are undergoing radiotherapy, chemotherapy, or antiangiogenic therapy.
When combined with fusion imaging including US with MRI, CEUS has several 
advantages over B-mode alone [43, 44]:
1. Detection of poor sonographic visibility tumor.
2. Better recognition of the tumor and edema tissue compared with reconstruc-
tive preoperative coplanar-enhanced MRI in real time and multiplane from 
different angles.
3. Application by neurosurgeons who lack the expertise in US technology as an 
easier way to discern the structure of the brain.
4. Improved orientation and compensation for the brain shift.
Recent reports highlighted other potential applications of CEUS in cranial onco-
logical surgery, although these experiences are still anecdotal with few cases reported. 
Apart from the evaluation of intraoperative resection control, CEUS has been used 
as biopsy guidance to correctly localize the needle and target the most representative 
samples for pathology [5, 45] or to guide and assess hemodynamic effects after intra-
operative embolization of highly vascularized tumors such as hemangioblastomas 
[20, 38]. In addition, CEUS use can space from a bedside technique adding helpful 
information not only in noninvasive staging of tumors but also in differentiating 
tumor recurrence from radionecrosis as postulated by Vicenzini et al. [46] and Mattei 
et al. [47]; relying on microbubble diffusion through vascularization radionecrosis 
shows a completely different, poorer, enhancement pattern compared to HGGs.
CEUS has thus proven its utility in:
1. Highlighting tumors and their phases compared to brain parenchyma [42].
2. Characterizing glioma grade [29, 30, 48].
3. Assessing vascularization and degree of overall perfusion [29, 30].
4. Showing vascular rearrangement that takes place with tumor removal [17].
5. Highlighting residual tumor (especially feasible in a 5-ALA setting) [10, 30, 39].
6. Aiding surgical decision-making through serial imaging assessment of surgical 
anatomy [5, 7, 41, 42].
7. Helping in differential diagnosis of radionecrosis with neoplastic tissue due to 
its lack of contrast enhancement [46, 47].
8. Guiding to intraoperative biopsy and tissue sampling [5, 45]
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4. Spinal tumors
Primary spinal tumors are relatively rare lesions, for which MRI represents 
the gold standard for diagnosis. Nevertheless, MRI may not always differenti-
ate accurately between different types of intramedullary tumors: even if not 
well defined nor standardized, the role of CEUS in this surgical field appears 
as a problem solver. Even though a small number of cases were reported, it has 
proven to be a simple and relatively inexpensive technique representing a real-
time dynamic procedure that can be performed during a spinal tumor surgery. Its 
benefits include:
1. Better characterization of the location of the intramedullary lesions [49, 50].
2. Easier identification of vascular structures, giving further insight in vascular 
deafferentation and then surgical removal [8, 9, 49, 50].
3. Possible combination with color Doppler to better identify the main arterial 
feeders and draining vessels [8, 9].
4. As for HGG surgery, CEUS helps in the identification of inadvertent  
remnants [8].
The important drawbacks in this setting are:
1. Possibility to analyze one portion of the lesion at the time.
2. Reduced visibility of low-flow veins and possible overestimation of small  
vessels due to blooming artifacts.
3. Less defined imaging due to a reduced depth of the explored surgical field 
compared to brain surgery [4, 8, 9]
5. Vascular applications
Providing an angiogram-like display of the parent and downstream vessel seg-
ments in high spatial resolution, CEUS might be a feasible tool for both aneurysm 
and arteriovenous malformation (AVM) treatment. Indeed, it could implement 
their intraoperative management by providing real-time imaging: this is true 
both in the visualization of the vascular supply before the intervention and in 
flow assessment at the end of the procedure [51]. Furthermore, since it allows the 
identification of target vessels even when covered by brain parenchyma, it could 
be synergistically used with ICG-VA, which relies on direct vessel visualization, in 
situations in which a complex approach is required [13, 52].
Focusing on aneurysms, CEUS was found particularly useful in occlusion follow-
up after endovascular treatment. As opposed to a neuro-oncological setting, in which 
CEUS examination can be performed only after craniotomy, in the vascular setting, 
it can amplify vessel resolution also during transcranial examination. CEUS can 
selectively monitor intracranial aneurysms and detect refilling rate in aneurysms with 
a minor neck remnant. In the end, they suggested to perform transcranial color-coded 
duplex sonography (TCCS) examination with contrast enhancement at the time 
of initial surveillance with digital subtraction angiography (DSA) and, if findings 
were similar, to undertake an additional follow-up by TCCS alone until changes in 
Neurosurgical Procedures - Innovative Approaches
8
aneurysm status. Transcranial examination is cost-effective, rapid, easily repeat-
able, and feasible compared to standard digital subtraction angiogram or angio-MRI 
monitoring.
To summarize, CEUS in the setting of intracranial aneurysms has the following 
advantages:
1. Accurate display of flow direction and velocity.
2. Increased focus and resolution, allowing detection of very low flow as often 
presented in coiled aneurysms.
3. Gives the possibility to be performed immediately as a control examination in 
the intensive care unit (ICU).
4. Produces less severe metal artifacts compared to other imaging modalities.
The main drawback underlined in both papers was the limited acoustic win-
dow in aneurysms located outside the circle of Willis, despite the introduction of 
contrast agent [25, 26].
In dural arteriovenous fistula (dAVF) surgery, both cranial and spinal, one of the 
most important steps is the correct identification of the fistulous site [53–55]. In the 
two reported cases [4, 56], CEUS allowed both pre- and post-ligation real-time visu-
alization of site of the fistula and blood flow changes occurring in the spinal cord and 
perimedullary plexus. Not only it does encompass the limitations of Doppler imaging, 
which can be used simultaneously to confirm the type of flow and flow dynamics, but, 
as already in the case of aneurysms, it might be integrated with other imaging modali-
ties such as fluorescence [11, 51]. However, larger series are needed to determine the 
significance of this tool in the obliteration of intradural spinal dAVFs [51] (Figure 4).
Pioneer experiences have recently been reported also in AVM surgery. Providing 
an angiogram-like display of the parent and downstream vessel segments in high 
spatial resolution, CEUS is a feasible tool for both aneurysms and AVM treat-
ments. Indeed, it could implement their intraoperative management by providing 
real-time imaging: this is true both in visualization of the vascular supply before 
the intervention and in flow assessment at the end of the procedure. Furthermore, 
since it allows the identification of target vessels even when covered by the brain 
parenchyma, it has been proposed as a complement to standard ICG-VA.
The integration of color Doppler sonography and CEUS allows to:
1. Accurately display flow direction and velocity within the nidus and in  
surrounding vessels
2. Identify AVM feeders from non-AVM-related vessels
3. Evaluate the flow modifications produced into the nidus after temporary  
occlusion of feeders
4. Assess completeness of devascularization and eventual residual flow to the AVM
5. Assess restored venous flow into surrounding veins before dissection and  
isolation of the venous compartments of the malformation
Knowledge of the vascular characteristics of the AVM and the relationships of 
the nidus with the brain parenchyma is mandatory during these complex surgical 
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procedures; hence, the real-time identification of the feeding arteries and draining 
veins is surely valuable during surgery. Basically, the operative strategy is guided 
throughout the procedure by several CEUS assessments with temporary clipping of 
the feeding vessel, and real-time confirmation of the hemodynamic modification 
inside the nidus is semiquantitatively evaluated both by means of color Doppler US 
and CEUS. This reduces the risk of inadvertently sacrificing parenchymal non-
AVM-related arterial vessels (Figure 5).
Figure 4. 
B-mode and color Doppler visualization of a spinal dAVF characteristic. Epidural standard B-mode imaging 
showing the spinal cord anatomical proportional plan features: Green arrow, dura mater; blue arrow, 
peridural venous plexus; yellow arrow, spinal cord gray matter; white arrow, spinal cord white matter; red 
arrows, vertebral arteries. Color Doppler sonography displaying radicular artery (red arrow) and engorged 
peridural veins (blue arrows) with a turbulent flow. Doppler US confirms the arterialized nature of peridural 
plexus veins. After CEUS administration the main feeders afferent to the lesion can be observed and the main 
venous arterialized drainage outgoing the lesion (red arrows), thus identifying fistulous point. Peridural venous 
vessels not directly related to the dAVF are not visualized at this early arterial stage (arterial stage).
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In advanced phases of dissection, CEUS allows the surgeon to:
a. Spatially identify in which area of the nidus residual flow is present.
b. Establish a gross estimation of the overall residual flow within the malforma-
tion (as CEUS enhancement is directly proportional to flow).
Furthermore, the restored venous flow into AVM draining veins can be reliably 
identified providing a final confirmation of completeness of nidal deafferentation, 
before the procedure is completed.
6. Stroke
An adequate supply of blood containing oxygen and nutrients is crucial for the 
recovery and survival of brain tissue. Monitoring of cerebral perfusion is essential 
in the prevention of secondary brain damage in patients with acute brain injury. 
CEUS has been suggested as a new method to measure cerebral perfusion in patients 
both with acute brain injury at the ICU and in the acute state of cerebral ischemia. 
The technique has a high temporal resolution which can be used at the bedside; 
moreover, the contrast enhancement can be used for visualization of the cerebral 
vasculature to overcome the restricted level of acoustic intensity. However, in this 
context the accuracy of CEUS for the detection of hyperperfusion has not yet been 
assessed.
This aligns with the idea that for patients after ischemic stroke, CEUS may serve 
as an additional clinical tool for the bedside evaluation of brain tissue perfusion 
and response to recanalization therapy, with more efforts to be made to improve 
its reliability [57–59]. However, when it comes to this clinical application, two key 
problems arise:
Figure 5. 
CEUS and color Doppler US evaluation of an AVM, in which main arterial feeders (red arrows) can be 
identified, as well as the nidus (green arrow) and venous drains (green arrow). Color Doppler shows the flow 
direction, arterial vs. venous flow, and confirms turbulent flow within the malformation.
11
Oncological, Vascular, and Spinal Uses of Contrast-Enhanced Ultrasound in Neurosurgery
DOI: http://dx.doi.org/10.5772/intechopen.91320
1. Different protocols were used by the involved research groups, and, more 
crucial, patients presenting with acute stroke were examined at different time 
windows.
2. Patients with insufficient insonation conditions were excluded in advance, and 
the percentage of stroke patients for which the technique could represent a 
consistent improvement remains questionable. Indeed, in cited studies [57–59], 
one of the inclusion criteria was a sufficient temporal acoustic window for 
conventional transcranial color-coded sonography.
As a last note, CEUS can be used as a follow-up strategy in stroke patients: it is a 
fast and repeatable bedside technique [3]. However, these potential advantages are 
undermined by (1) a small sample of studies; (2) non-validated comparison with 
the other imaging technique already in use in this particular area; and (3) the need 
for specific ecographic equipment.
7. Carotid plaques
Carotid atherosclerotic disease represents a major current health problem 
accounting for approximately 20% of all cases of cerebral ischemia. Risk stratifi-
cation and patient management are traditionally based on the presence or absence 
of symptoms and the degree of stenosis, both of which have been found to cor-
relate with the occurrence of stroke. US is the cornerstone of both screening and 
diagnostic approach of carotid disease, and introduction of CE has been providing 
promising results, leading to the publication of recommendation of use [28, 60]. 
An impressive number of works demonstrated CEUS is a feasible and effective 
tool to:
1. Analyze plaque morphology and characteristics [61]
2. Identify vulnerable plaques and detect neovascularization [62–65]
3. Perioperatively assess the procedure to be performed [66–68]
Moreover, a comparison and a proof of the relationship between CEUS and 
3DT1-WI MRI plaque imaging were recently published [69]. However, on board 
with the purpose of this review, we decided to focus only on those works in which 
a prospective relationship between CEUS on carotid intraplaque neovasculariza-
tion and ischemic stroke was analyzed. The grade of contrast enhancement was 
an independent risk factor for ischemic stroke or recurrent transitory ischemic 
attack. Therefore, the grade of CEUS contrast enhancement could become a pre-
dictive index of ischemic stroke, identifying those patients in need of an effective 
treatment. A potential source of bias coming from the exclusive selection of large 
plaques, a semiquantitative grading system, and a relatively small sample size are 
however important limitations associated with this finding.
8. Conclusions
CEUS has reached in recent years a wide utilization in various neurosurgical 
fields, mainly in neuro-oncological surgery. Despite its main limitations in being 
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an operator-dependent technique and its shared drawbacks with US technology, 
it revealed itself as a promising tool: CEUS is comparable and complementary to 
traditional imaging techniques, allows for a serial assessment, is easily performable 
in different settings, and has a wide range of future applications yet to be explored.
© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
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